Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2006; Volume 186, Supplement 650
Joint Meeting of The German Society of Physiology and The Federation of European Physiological Societies 2006
3/26/2006-3/29/2006
Ludwig-Maximilians-University, Munich


EFFECTS OF ALLOXAN-INDUCED AND INUSLIN RESISTANT DIABETES ON GONADOTROPINS AND CORPUS LUTEUM FUNCTION IN FEMALE SPRAGUE DAWLEY RATS
Abstract number: PM10P-4

Arikawe1 AP, Daramola1 AO, Odofin1 A, Ajala1 W, Obika1 LFO

1Physiology Department, College of Medicine, University of Lagos, Idi Araba, Lagos., Lagos, Nigeria

The study aimed to investigate the effects of diabetes and insulin resistance on gonadotropins and corpus luteum function in female rats. Female Sprague Dawley rats (130 -150g) were divided into two categories and made diabetic by single intravenous injection of alloxan (40 mg/kg) and insulin resistant by fructose feeding (25% fructose). Rats were anaesthetized, followed by laparatomy. Blood was obtained by cardiac puncture for measurement of LH, FSH, oestrogen and progesterone concentrations by radioimmunoassay. Ovary was isolated, weighed, fixed in 10% formol saline and processed for histological studies.

Serum FSH was significantly higher in experimental groups of animals while serum LH was not significantly different in the 3 groups. Serum oestrogen was significantly higher in alloxan-induced and inuslin resistant groups while serum progesterone was not significantly different. Ovarian weight was significantly reduced in alloxan-induced and insulin resistant groups. Ovarian histology confirms insulin resistance as a common feature of polycystic ovary syndrome thus predisposes to infertility. We conclude that diabetes mellitus alters corpus luteum functions and predisposes to polycystic ovary syndrome in female rats.

To cite this abstract, please use the following information:
Acta Physiologica 2006; Volume 186, Supplement 650 :PM10P-4

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE